drugset / Trial / NCT07333716
Desloratadine in Patients With Ulcerative Colitis
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate safety and therapeutic efficacy of antihistamine (desloratadine) on inflammation and disease activity when administered as adjuvant therapies with the traditional therapy 5-aminosalisylic acid (mesalamine) in patients with mild to moderate ulcerative colitis.
Timeline
- Start
- 2026-01-26
- Primary completion
- 2027-02
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Desloratadine | Small molecule | 5 mg | — |
| Comparator | Mesalamine | Small molecule | 1000 mg | — |